These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 32492199)

  • 21. Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).
    Qaseem A; Yost J; Etxeandia-Ikobaltzeta I; Abraham GM; Jokela JA; Miller MC; Forciea MA; Humphrey LL;
    Ann Intern Med; 2021 Dec; 174(12):W116-W117. PubMed ID: 34606308
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of SARS-CoV-2: How far have we reached?
    Ahsan W; Javed S; Bratty MA; Alhazmi HA; Najmi A
    Drug Discov Ther; 2020 May; 14(2):67-72. PubMed ID: 32336723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The COVID-19 pandemic: consequences for nephrology.
    Bruchfeld A
    Nat Rev Nephrol; 2021 Feb; 17(2):81-82. PubMed ID: 33257872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of an Immunocompromised Pediatric Patient With Multiple Hospitalizations for Symptomatic COVID-19.
    DeVine MN; Maxwell S; Haynes AS; MacBrayne CE; Boguniewicz J
    J Pediatr Hematol Oncol; 2022 Jan; 44(1):e293-e295. PubMed ID: 33235142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.
    Ison MG; Wolfe C; Boucher HW
    JAMA; 2020 Jun; 323(23):2365-2366. PubMed ID: 32407438
    [No Abstract]   [Full Text] [Related]  

  • 26. Emergency Use Authorization for Remdesivir and Its Potential Implications.
    Ochoa Chaar CI; Makuch R
    Ther Innov Regul Sci; 2021 Mar; 55(2):270-271. PubMed ID: 32880853
    [No Abstract]   [Full Text] [Related]  

  • 27. A 10-Year-old Girl With Late Acute Lymphoblastic Leukemia Recurrence Diagnosed With COVID-19 and Treated With Remdesivir.
    Gadzińska J; Kuchar E; Matysiak M; Wanke-Rytt M; Kloc M; Kubiak JZ
    J Pediatr Hematol Oncol; 2022 Mar; 44(2):e537-e538. PubMed ID: 33885040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repurposing antimalarials and other drugs for COVID-19.
    Schlagenhauf P; Grobusch MP; Maier JD; Gautret P
    Travel Med Infect Dis; 2020; 34():101658. PubMed ID: 32247925
    [No Abstract]   [Full Text] [Related]  

  • 29. Immune responses and therapeutic challenges in paediatric patients with new-onset acute myeloid leukaemia and concomitant COVID-19.
    Patel PA; Lapp SA; Grubbs G; Edara VV; Rostad CA; Stokes CL; Pauly MG; Anderson EJ; Piantadosi A; Suthar MS; Khurana S; Sabnis HS
    Br J Haematol; 2021 Aug; 194(3):549-553. PubMed ID: 34096051
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of COVID-19 in high-risk outpatients.
    Med Lett Drugs Ther; 2022 Feb; 64(1643):e1. PubMed ID: 35134051
    [No Abstract]   [Full Text] [Related]  

  • 31. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?
    Thalha AMM; Lee YY; Besari A; Omar SFS
    J R Coll Physicians Edinb; 2020 Jun; 50(2):159-161. PubMed ID: 32568289
    [No Abstract]   [Full Text] [Related]  

  • 32. Streptococcus pneumoniae coinfection in hospitalised patients with COVID-19.
    Anton-Vazquez V; Clivillé R
    Eur J Clin Microbiol Infect Dis; 2021 Jun; 40(6):1353-1355. PubMed ID: 33462723
    [No Abstract]   [Full Text] [Related]  

  • 33. A comprehensive review on sarilumab in COVID-19.
    Khiali S; Rezagholizadeh A; Entezari-Maleki T
    Expert Opin Biol Ther; 2021 May; 21(5):615-626. PubMed ID: 33161757
    [No Abstract]   [Full Text] [Related]  

  • 34. Audio Interview: A Potential New Agent to Treat Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Dec; 385(26):e101. PubMed ID: 34936745
    [No Abstract]   [Full Text] [Related]  

  • 35. Experts Discuss COVID-19-Remdesivir, Vaccines, and More.
    JAMA; 2020 Aug; 324(8):730-731. PubMed ID: 32777002
    [No Abstract]   [Full Text] [Related]  

  • 36. The race against COVID-19.
    Nat Nanotechnol; 2020 Apr; 15(4):239-240. PubMed ID: 32303704
    [No Abstract]   [Full Text] [Related]  

  • 37. Anti-infective therapy against SARS-CoV-2: some light at the end of the tunnel?
    Montravers P; Kantor E; Gouel-Cheron A
    Anaesth Crit Care Pain Med; 2020 Dec; 39(6):695-697. PubMed ID: 33096261
    [No Abstract]   [Full Text] [Related]  

  • 38. A Proposed Lottery System to Allocate Scarce COVID-19 Medications: Promoting Fairness and Generating Knowledge.
    White DB; Angus DC
    JAMA; 2020 Jul; 324(4):329-330. PubMed ID: 32579158
    [No Abstract]   [Full Text] [Related]  

  • 39. Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection.
    Ye ZW; Yuan S; Chan JF; Zhang AJ; Yu CY; Ong CP; Yang D; Chan CC; Tang K; Cao J; Poon VK; Chan CC; Cai JP; Chu H; Yuen KY; Jin DY
    Emerg Microbes Infect; 2021 Dec; 10(1):291-304. PubMed ID: 33538646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Challenges Ahead With Monoclonal Antibodies: From Authorization to Access.
    Goldstein RH; Walensky RP
    JAMA; 2020 Dec; 324(21):2151-2152. PubMed ID: 33175110
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.